Janssen Search
Search results
Janssen to Highlight Scientific Advances and Commitment to Transform Cancer Care at ASCO and EHA with More than 90 Presentations Showcasing Robust, Differentiated Portfolio and Pipeline in Hematologic Malignancies and Solid Tumors
May 18, 2023 United States Launch of Multidisciplinary Council of Experts Call-to-Action During EHA Demonstrates Continued Commitment to Innovation in Multiple Myeloma RARITAN, N.J., May 18, 2023 — The Janssen Pharmaceutical Companies of Johnson & ...
Mark Oswald
Mark Oswald brings more than twenty years of combined technical leadership, software development, program and product management and technology consulting experience. At Janssen Healthcare Innovation (JHI), Mark is responsible for leading the global ...
Advancing the Power of Monoclonal Antibodies
Advancing the Power and Promise of Monoclonal Antibodies Janssen was one of the first companies to recognize the diagnostic and therapeutic potential of monoclonal antibodies, and today we are continuing to apply that expertise to explore their power and ...
Cardiovascular, Metabolism & Retina
Cardiovascular, Metabolism & Retina At Janssen Cardiovascular, Metabolism (CVM) & Retina, we take on the most pervasive diseases that burden hundreds of millions of people and healthcare systems around the world. As part of this long-standing ...
Health Management for Women
Collaboration with the International Partnership for Microbicides Women and girls, particularly in sub-Saharan Africa where the HIV epidemic has hit hardest, remain particularly vulnerable to infection. New HIV prevention tools are needed to empower women ...
For Patients & Caregivers
Article Type: Infectious Diseases & Vaccines For Patients & Caregivers We are focused on tackling complex infectious diseases, finding the right paths of intervention, and ensuring they reach those in need. We are committed to empowering patients ...
PH Commercialization
Commercialization Focusing our efforts in raising the bar for pulmonary hypertension (PH) management. At Janssen, we are focusing our worldwide scientific and commercial expertise to help raise the bar in the management of PH. Janssen brings to the PH ...
Richard Appiah
RICHARD APPIAH VICE PRESIDENT DISEASE AREA COMMERCIAL LEADER GASTROENTEROLOGY Richard Appiah is Vice President, Disease Area Commercial Leader, Gastroenterology for the Immunology Therapeutic Area at Janssen Global Services. In this role, he is ...
Questions to ask your doctor
Article Block Text: Article Type: Compassionate Use & Pre-Approval Access Questions to ask your doctor If you and your doctor are considering the use of investigational medicines that have not yet been approved by government health authorities, ...
Colorectal Cancer
Colorectal Cancer Colorectal cancer (CRC) is the third most common cancer worldwide, with over 1.8 million new cases in 2018 alone. 1 The most common hereditary CRC syndromes are familial adenomatous polyposis (FAP) and lynch syndrome (LS). Frequent ...